ES2156603T3 - Medicamentos a base de una mezcla sinergetica de metronidazol y de clindamicina. - Google Patents

Medicamentos a base de una mezcla sinergetica de metronidazol y de clindamicina.

Info

Publication number
ES2156603T3
ES2156603T3 ES95923419T ES95923419T ES2156603T3 ES 2156603 T3 ES2156603 T3 ES 2156603T3 ES 95923419 T ES95923419 T ES 95923419T ES 95923419 T ES95923419 T ES 95923419T ES 2156603 T3 ES2156603 T3 ES 2156603T3
Authority
ES
Spain
Prior art keywords
metronidazol
clindamycin
synthetic mixture
medications based
medications
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95923419T
Other languages
English (en)
Inventor
Janusz Czernielewski
Josiane Les Vergers De V Allec
Martine Bouclier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Research and Development SNC
Original Assignee
Galderma Research and Development SNC
Centre International de Recherches Dermatologiques Galderma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Research and Development SNC, Centre International de Recherches Dermatologiques Galderma filed Critical Galderma Research and Development SNC
Application granted granted Critical
Publication of ES2156603T3 publication Critical patent/ES2156603T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

LA INVENCION SE REFIERE A LA UTILIZACION DE METRONIDAZOL, O PREFERENTEMENTE DE UNA ASOCIACION DE METRONIDAZOL Y DE CLINDAMICINA,COMO PRINCIPIO ACTIVO, PARA LA FABRICACION DE COMPOSICIONES FARMACEUTICAS, MAS PARTICULARMENTE DERMATOLOGICAS, DESTINADAS A UN TRATAMIENTO ANTIINFLAMATORIA POR VIA TOPICA.
ES95923419T 1994-07-06 1995-06-20 Medicamentos a base de una mezcla sinergetica de metronidazol y de clindamicina. Expired - Lifetime ES2156603T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9408350A FR2722098B1 (fr) 1994-07-06 1994-07-06 Nouveaux medicaments a base de metro-nidazole ou d'un melange synergetique de metronidazole et de clindamycine

Publications (1)

Publication Number Publication Date
ES2156603T3 true ES2156603T3 (es) 2001-07-01

Family

ID=9465069

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95923419T Expired - Lifetime ES2156603T3 (es) 1994-07-06 1995-06-20 Medicamentos a base de una mezcla sinergetica de metronidazol y de clindamicina.

Country Status (11)

Country Link
US (1) US5849776A (es)
EP (1) EP0768884B1 (es)
JP (1) JP3006888B2 (es)
AU (1) AU2798495A (es)
CA (1) CA2191129C (es)
DE (1) DE69520041T2 (es)
ES (1) ES2156603T3 (es)
FR (1) FR2722098B1 (es)
IL (1) IL114276A0 (es)
WO (1) WO1996001117A1 (es)
ZA (1) ZA954881B (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007021167A1 (es) * 2005-08-12 2007-02-22 Espinosa Abdala Leopoldo De Je Formulaciones farmacéuticas sólidas, semisólidas, en suspensión, en solución, en emulsión o en jarabe conte niendo clindamicina y uno o más de los miembros de la familia de los azoles

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU775606B2 (en) * 1998-08-31 2004-08-05 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Methimazole derivatives and tautomeric cyclic thiones to treat autoimmune diseases
CN1304001C (zh) * 1999-07-16 2007-03-14 株式会社昭荣 含有硝基咪唑的皮肤病外用药
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6565882B2 (en) 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6468989B1 (en) 2000-07-13 2002-10-22 Dow Pharmaceutical Sciences Gel compositions containing metronidazole
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US6541014B2 (en) 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
IL142037A0 (en) * 2001-03-15 2002-03-10 Agis Ind 1983 Ltd Pharmaceutical compositions containing a non-steroidal anti-inflammatory drug
WO2002094179A2 (en) * 2001-05-23 2002-11-28 J.B. Chemicals & Pharmaceuticals Ltd. Novel topical microbicidal compositions
US6881726B2 (en) * 2001-12-24 2005-04-19 Dow Pharmaceutical Sciences Aqueous compositions containing metronidazole
US20040171561A1 (en) * 2002-09-03 2004-09-02 Popp Karl F. Topical formulations for treatment of rosacea
US7060729B2 (en) * 2002-09-05 2006-06-13 Reza Babapour Composition and method for treating skin
EA014372B1 (ru) 2003-01-24 2010-10-29 Стифел Рисерч Оустрэйлиа Пти Лтд. Пена на основе фосфата клиндамицина
EP1648418A4 (en) 2003-07-21 2011-11-16 Middlebrook Pharmaceuticals Inc ANTIBIOTIC PRODUCT, ITS USE AND FORMULATION
CA2533292C (en) 2003-07-21 2013-12-31 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
EP1648415A4 (en) 2003-07-21 2011-11-16 Middlebrook Pharmaceuticals Inc ANTIBIOTIC PRODUCT, ITS USE AND FORMULATION
WO2005016311A1 (en) 2003-08-11 2005-02-24 Advancis Pharmaceutical Corporation Robust pellet
CA2535398C (en) 2003-08-12 2013-11-12 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
EP1658034A4 (en) 2003-08-29 2011-06-22 Middlebrook Pharmaceuticals Inc ANTIBIOTIC PRODUCT, ITS USE AND FORMULATION
WO2005027877A1 (en) 2003-09-15 2005-03-31 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
US7205006B2 (en) * 2003-09-25 2007-04-17 Prime Pharmaceutical Corporation Mahonia aquifolium extract, extraction process and pharmaceutical composition containing the same
FR2866569B1 (fr) * 2004-02-20 2007-08-24 Galderma Res & Dev Utilisation du metronidazole pour la preparation d'une composition pharmaceutique destinee a traiter des pathologies liees au recepteur de type b de l'interleukine 8 et/ou au recepteur de type 1 de pacap
FR2866570B1 (fr) * 2004-02-20 2007-08-24 Galderma Res & Dev Utilisation du metronidazole pour la preparation d'une composition pharmaceutique destinee a traiter une inflammation cutanee
FR2887149B1 (fr) 2005-06-17 2007-08-03 Galderma Sa Procede de solubilisation du metronidazole
US8715727B2 (en) 2004-07-02 2014-05-06 Shionogi Inc. Tablet for pulsed delivery
EP1671623A1 (en) * 2004-10-01 2006-06-21 Giuseppe Vrespa Composition for use in the antibacterial and antiinflammatory treatment of the oral cavity
CN1297563C (zh) * 2004-10-14 2007-01-31 盛四龙 克林霉素甲硝唑阴道栓
FR2882552B1 (fr) * 2005-02-25 2008-12-26 Galderma Sa Gel aqueux de haute stabilite a base de metronidazole et procedes pour leur preparation
US20060286054A1 (en) * 2005-06-15 2006-12-21 Apollo Pharmaceutical, Inc. Pharmaceutical compositions for the treatment of psoriasis
CN100370994C (zh) * 2005-08-24 2008-02-27 王卫阳 克林霉素甲硝唑软膏及其制备方法
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
WO2010047831A1 (en) * 2008-10-23 2010-04-29 Nycomed Us Inc. Stable metronidazole gel formulations
US20100273756A1 (en) * 2009-04-27 2010-10-28 Reza Babapour Adjunctive formulation and methods for palliation of fine wrinkles, mottled hyperpigmentation, tactile roughness of facial skin and related disorders
CN103006681B (zh) * 2012-12-04 2014-07-09 哈尔滨乐泰药业有限公司 治疗痤疮的复方乳膏及其制备方法
WO2016069952A1 (en) * 2014-10-31 2016-05-06 Sreedhar Rao Rayudu Anti-acne composition and methods of use
US11160867B2 (en) * 2017-05-11 2021-11-02 Auburn University Anti-protozoal compounds and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4018918A (en) * 1975-05-20 1977-04-19 The Upjohn Company Topical clindamycin preparations
US4837378A (en) * 1986-01-15 1989-06-06 Curatek Pharmaceuticals, Inc. Topical metronidazole formulations and therapeutic uses thereof
WO1988006888A1 (en) * 1987-03-20 1988-09-22 Curatek Pharmaceuticals, Inc. Novel topical metronidazole formulations and therapeutic uses thereof
US4957918A (en) 1988-06-09 1990-09-18 Leonard Bloom Topical treatment of blepharitis

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007021167A1 (es) * 2005-08-12 2007-02-22 Espinosa Abdala Leopoldo De Je Formulaciones farmacéuticas sólidas, semisólidas, en suspensión, en solución, en emulsión o en jarabe conte niendo clindamicina y uno o más de los miembros de la familia de los azoles

Also Published As

Publication number Publication date
FR2722098A1 (fr) 1996-01-12
WO1996001117A1 (fr) 1996-01-18
JP3006888B2 (ja) 2000-02-07
DE69520041T2 (de) 2001-06-21
FR2722098B1 (fr) 1996-08-23
IL114276A0 (en) 1995-10-31
CA2191129A1 (fr) 1996-01-18
ZA954881B (en) 1996-01-30
DE69520041D1 (de) 2001-03-08
EP0768884A1 (fr) 1997-04-23
US5849776A (en) 1998-12-15
JPH10500700A (ja) 1998-01-20
AU2798495A (en) 1996-01-25
CA2191129C (fr) 2001-06-19
EP0768884B1 (fr) 2001-01-31

Similar Documents

Publication Publication Date Title
ES2088312T3 (es) Formulacion de liberacion controlada que contiene tramadol.
WO2002011764A3 (en) PHARMACEUTICAL COMPOSITIONS
ECSP105178A (es) Compuestos de aril urea en combinación con otros agentes citostáticos o citotóxicos para el tratamiento de cáncer en humanos
ES2421948T3 (es) Compuestos y composiciones para suministrar agentes activos
BR0114799A (pt) Compostos de ácido cianofenoxi carboxìlico e composições para liberar agentes ativos
GT199900203A (es) Composiciones de celecoxib.
DE69529670D1 (de) Oxazolidinon derivate und diese enthaltende pharmazeutische zusammensetzungen
CO4560552A1 (es) Antagonistas de receptores de taquicininas no peptidicos
AR032293A1 (es) Estuche farmaceutico
DK1300398T3 (da) Propan-1,3-dionderivat
ATE302616T1 (de) Oral anzuwendende arzneizusammensetzungen mit gesteuerter wirkstoffabgabe
BRPI0411770A (pt) dispositivo aperfeiçoado de distribuição
BR9916575A (pt) Composição farmacêutica de liberação controlada com mesilato de tilidina como substância-ativa
BR0209327A (pt) Composição para tratamento de constipação induzida por drogas
DK1121127T3 (da) Orale farmaceutiske sammensætninger, som indeholder buprenorphin
AR032872A1 (es) Composicion para aclarar la piel y el metodo de aplicacion
AR031649A1 (es) Composicion farmaceutica de dronedarona para administracion parenteral
TW200507838A (en) Active substance combination comprising a 2,5-dihydroxybenzenesulfonic compound and a potassium ion channel modulator
ES2171669T3 (es) Composicion farmaceutica que contiene hidrocloruro de tiagabina y su procedimiento de preparacion.
ES2156215T3 (es) Utilizacion de un conjugado en el tratamiento y/o diagnostico de enfermedades inflamatorias.
PA8549401A1 (es) Complejo que comprende factor inhibidor de osteoclastogenesis y polisacarido
BRPI0414114A (pt) uso de defibrotide, formulação, e, método para tratar um mamìfero afetado por um tumor
ECSP003685A (es) Formulaciones orales de liberacion controlada
BR9810433A (pt) Composições anti-helmìnticas
DK1729732T3 (da) Anioniske hydrogelmatricer med pH-afhængig frigivelse som lægemiddelbærere

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 768884

Country of ref document: ES